Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD

被引:3
|
作者
Nag, Niharika [1 ]
Tripathi, Timir [1 ,2 ]
机构
[1] North Eastern Hill Univ, Dept Biochem, Mol & Struct Biophys Lab, Shillong 793022, India
[2] Indira Gandhi Natl Open Univ IGNOU, Reg Directors Office, Reg Ctr Kohima, Kohima 797001, India
来源
ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 17期
关键词
Nucleocytoplasmic transport; amyotrophic lateral sclerosis; ALS/FTLD; Nup62; proteinopathy; TDP-43; FG-Nups; condensates; NUCLEOCYTOPLASMIC TRANSPORT; DISRUPTS;
D O I
10.1021/acschemneuro.2c00480
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nucleocytoplasmic transport (NCT) is impaired in C9-ALS/FTLD, a common genetically caused form of ALS and FTLD. The NCT is regulated by proteins called FG-nucleoporins (FG-Nups), with domains enriched in phenylalanine-glycine repeats. However, the relationship between FG-Nups and TDP-43, an RBP found to be mislocalized in ALS/FTLD patients, has not been defined. A recent study found that a critical protein, FG-Nup62, is mislocalized both in vivo and in vitro in diseased states. The mislocalized Nup62 was colocalized with TDP-43 in cytoplasmic inclusions and promoted its liquid-to-solid transition. The work highlights the involvement of Nup62 in the pathogenesis of ALS/FTLD and the interaction between Nup62 and TDP-43.
引用
收藏
页码:2544 / 2546
页数:3
相关论文
共 50 条
  • [41] TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration
    Gao, Ju
    Wang, Luwen
    Yan, Tingxiang
    Perry, George
    Wang, Xinglong
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 100
  • [42] New terminology for a common TDP-43 proteinopathy
    Kurucu, Hatice
    Spires-Jones, Tara
    Smith, Colin
    LANCET NEUROLOGY, 2019, 18 (08): : 714 - 715
  • [43] Inflammation Induces TDP-43 Mislocalization and Aggregation
    Correia, Ana Sofia
    Patel, Priyanka
    Dutta, Kallol
    Julien, Jean-Pierre
    PLOS ONE, 2015, 10 (10):
  • [44] Mechanisms of TDP-43 Proteinopathy Onset and Propagation
    Chen, Han-Jou
    Mitchell, Jacqueline C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [45] Optogenetic Induction of TDP-43 Proteinopathy In Vivo
    Otte, Charlton
    Mann, Jacob
    Pandey, Udai
    Donnelly, Christopher
    NEUROLOGY, 2019, 92 (15)
  • [46] Propagation of TDP-43 proteinopathy in neurodegenerative disorders
    Rachel Keszycki
    Pouya Jamshidi
    Allegra Kawles
    Grace Minogue
    Margaret E.Flanagan
    Colleen R.Zaccard
    M.-Marsel Mesulam
    Tamar Gefen
    Changiz Geula
    NeuralRegenerationResearch, 2022, 17 (07) : 1498 - 1500
  • [47] TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy
    Fei Mao
    John L. Robinson
    Travis Unger
    Marijan Posavi
    Defne A. Amado
    Lauren Elman
    Murray Grossman
    David A. Wolk
    Edward B. Lee
    Vivianna M. Van Deerlin
    Sílvia Porta
    Virginia M. Y. Lee
    John Q. Trojanowski
    Alice S. Chen-Plotkin
    Acta Neuropathologica, 2021, 142 : 629 - 642
  • [48] TDP-43 Proteinopathy Specific Biomarker Development
    Cordts, Isabell
    Wachinger, Annika
    Scialo, Carlo
    Lingor, Paul
    Polymenidou, Magdalini
    Buratti, Emanuele
    Feneberg, Emily
    CELLS, 2023, 12 (04)
  • [49] The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
    Kawakami, Ito
    Arai, Tetsuaki
    Hasegawa, Masato
    ACTA NEUROPATHOLOGICA, 2019, 138 (05) : 751 - 770
  • [50] TDP-43 pathology in FTLD-subtypes
    Nishihira, Yasushi
    Mao, Qinwen
    Kohler, Missia
    Coppola, Giovanni
    Rademakers, Rosa
    Rademaker, Alfred
    Weintraub, Sandra
    Mesula, M-Marsel
    Geula, Changiz
    Bigio, Eileen H.
    BRAIN PATHOLOGY, 2019, 29 : 80 - 80